The Department of Medicine has a long-standing tradition of excellence in compassionate patient care, innovative research and distinguished education, founded on the twin principles of caring and investigation.
All internists are at heart a strange mix of both detective and engineer. We are attracted to Internal Medicine in the first place because we are detectives, we want to solve problems, and the problems we want to solve are what makes people sick, because it hurts us when someone suffers, when someone presents with a complex of symptoms that causes them pain. We cannot help ourselves, when faced with someone who is hurting we cannot help but respond, to investigate. “Why is this happening?” we ask ourselves, late at night, laying bed, why? Driving into work early in the morning, while it is still dark, tell me you have not done this; of course you have, you are in Internists. This drives you, it makes you crazy, the not knowing, not able to understand why. This is the heart of an Internist.
But there is another part to your heart, if you are an Internist. This is the part that, when you finally understand the reason for the suffering, you want to attack it, you want to fix it. Once you understand the reason for the problem, you and I cannot rest until it is fixed. Read More...
On Friday, May 6th, our department won multiple awards from the 2016 medical student graduating class. Congratulations to the winners of these special awards. For behind every successful faculty award, there […]
Our 2015-2016 Consult Service Award winners were announced on Saturday, April 30th. We’d like to congratulate Palliative Care, Infectious Disease and Endocrinology Consult Services on their wonderful work.
The Department of Medicine and Samuel Waxman Cancer Research Foundation are proud to announce that Dr. Robert Hromas, Chair of Medicine, has joined SWCRF’s scientific advisory board! Dr. Hromas, who […]
Dr. Hromas was recently interviewed at the ASH (American Society of Hematology) Annual Meeting 2015, discussing the progress in blood cancers, in particular Myeloma and CLL. “This is an enormously exciting […]